サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1388219

臨床検査サービスの世界市場 - 戦略と動向、アッセイタイプ別、場所別、製品タイプ別、国別予測 - エグゼクティブコンサルタントガイド付き（2024年～2028年）

Global Clinical Medical Laboratory Services Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides. 2024 to 2028
出版日: | 発行: Howe Sound Research | ページ情報: 英文 357 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
臨床検査サービスの世界市場 - 戦略と動向、アッセイタイプ別、場所別、製品タイプ別、国別予測 - エグゼクティブコンサルタントガイド付き（2024年～2028年）
出版日: 2023年10月11日
発行: Howe Sound Research
ページ情報: 英文 357 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床検査室はCOVIDの課題に立ち向かいましたが、パンデミックの終焉は診断への新たなアプローチを生み出しました。ポイントオブケアと自己検査は臨床検査サービスの長期的な需要を脅かしていますが、分子診断が急成長を牽引しています。

当レポートは、世界の臨床検査サービス市場について調査し、市場の概要とともに、アッセイタイプ別、場所別、製品タイプ別、国別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

  • 臨床検査の新たな需要
  • 機会の定義
  • 調査手法
  • 展望：ヘルスケアとIVD産業

第3章 市場の概要

  • 市場参入組織
    • 学術研究機関
    • 診断試験開発者
    • 計装サプライヤー
    • 薬品・試薬メーカー
    • 病理サプライヤー
    • 独立系臨床検査室
    • 公共の国立/地域研究所
    • 病院検査室
    • 臨床検査室
    • 監査機関
    • 認証機関
  • セグメンテーション- さまざまなアプローチ
  • 臨床検査業界の構造
  • 国と地域の多様性

第4章 市場動向

  • 成長促進要因
  • 成長抑制要因
  • 自動化、検査室動向

第5章 臨床検査サービスの最近の展開

第6章 主要企業のプロファイル

  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • American Bio-Clinical Laboratories, Int'l
  • ARUP Laboratories
  • Ascend Clinical
  • Assurance Scientific Laboratories
  • Bio-Reference Laboratories
  • Bioscientia Institut für Medizinische Diagnostik GmbH
  • BP Healthcare Group
  • Clinical Reference Laboratory
  • Clongen Laboratories
  • CompuNet Clinical Laboratories
  • Diagnósticos da América
  • DIAN Diagnostics Co., Ltd.
  • Enzo Biochem
  • Eone Laboratories
  • Eurofins Scientific
  • Exagen Diagnostics
  • Genzyme Corporation
  • Gribbles Pathology
  • Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • Integrated Regional Laboratories
  • KDL Group
  • Laboratory Corporation of America
  • Lifelabs
  • Mayo Clinic Laboratories
  • Mid America Clinical Laboratories
  • MNG Labs
  • Myriad Genetics/Myriad RBM
  • NeoGenomics
  • OncoDNA
  • Pathology, Inc.
  • ProPhase Labs
  • Psychemedics Corporation
  • Quest Diagnostics
  • RDL Reference Laboratory
  • Sonic Healthcare
  • Sophia Genetics
  • Spectra Laboratories
  • Synlab
  • Sysmex Inostics
  • Unilabs
  • Werfen

第7章 世界の臨床検査市場

  • 国別 - 概要
  • アッセイタイプ別 - 概要
  • 場所別 - 概要
  • 製品別 - 概要

第8章 世界の臨床検査診断市場- アッセイタイプ別

  • 化学
  • 微生物学
  • 血液学
  • 解剖病理学
  • 分子診断学

第9章 世界の臨床検査診断市場- 場所別

  • 入院病院
  • 外来病院
  • 独立系臨床検査室
  • 病院検査室
  • その他の検査室

第10章 世界の臨床検査診断市場- 製品別

  • 装置
  • 試薬
  • 労務
  • 諸経費
  • その他

第11章 臨床検査の将来

第12章 付録

図表

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Clinical Laboratory Departments and Segments
  • Table 3: Laboratory Management Focus-Different Approaches
  • Table 4: Key Segmentation Variables Going Forward
  • Table 5: Factors Affecting Local Clinical Testing Demand
  • Table 6: Seven Factors Driving Growth
  • Table 7: Alternative Medicine Segments
  • Table 8: Six Factors Limiting Growth
  • Table 9: Seven Key Diagnostic Laboratory Technology Trends
  • Table 10: - Global Market by Region
  • Table 11: Global Market by Assay Type
  • Table 12: Global Market by Place
  • Table 13: Global Market by Product
  • Table 14: Chemistry by Country
  • Table 15: Microbiology by Country
  • Table 16: Hematology by Country
  • Table 17: Anatomic Pathology by Country
  • Table 18: Molecular Diagnostics by Country
  • Table 19: Esoteric by Country
  • Table 20: In Patient Hospital by Country
  • Table 21: Out Patient Hospital by Country
  • Table 22: Independent Laboratory by Country
  • Table 23: Physicians Office Laboratory by Country
  • Table 24: Other Laboratory by Country
  • Table 25: Instruments by Country
  • Table 26: Reagents by Country
  • Table 27: Labour by Country
  • Table 28: Overhead by Country
  • Table 29: Other Product by Country
  • Table 30: Clinical Lab Fee Schedule
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays

Table of Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: The Road to Diagnostics
  • Figure 3: The Changing Age of The World's Population
  • Figure 4: Health Care Consumption by Age
  • Figure 5: Cancer Incidence-Age at Diagnosis
  • Figure 6: Centralized vs. Decentralized Laboratory Service
  • Figure 7: A Highly Multiplexed Syndromic Testing Unit
  • Figure 8: The Real Cost to Sequence the Human Genome
  • Figure 9: The Codevelopment Process
  • Figure 10: Comparing MDx Diagnostic and Traditional Testing
  • Figure 11: Global Market Pareto Chart
  • Figure 12: Global Market by Assay Type - Base vs. Final
  • Figure 13: Global Market by Assay Type Base Year
  • Figure 14: Global Market by Assay Type End Year
  • Figure 15: Assay Type Share by Year
  • Figure 16: Assay Type Segments Growth
  • Figure 17: Global Market by Place - Base vs. Final
  • Figure 18: Global Market by Place Base Year
  • Figure 19: Global Market by Place End Year
  • Figure 20: Place Share by Year
  • Figure 21: Place Segments Growth
  • Figure 22: Global Market by Product - Base vs. Final
  • Figure 23: Global Market by Product Base Year
  • Figure 24: Global Market by Product End Year
  • Figure 25: Product Share by Year
  • Figure 26: Product Segments Growth
  • Figure 27: Chemistry Growth
  • Figure 28: Microbiology Growth
  • Figure 29: Hematology Growth
  • Figure 30: Anatomic Pathology Growth
  • Figure 31: Molecular Diagnostics Growth
  • Figure 32: Esoteric Growth
  • Figure 33: In Patient Hospital Growth
  • Figure 34: Out Patient Hospital Growth
  • Figure 35: Independent Laboratory Growth
  • Figure 36: Physicians Office Laboratory Growth
  • Figure 37: Other Laboratory Growth
  • Figure 38: Instruments Growth
  • Figure 39: Reagents Growth
  • Figure 40: Labour Growth
  • Figure 41: Overhead Growth
  • Figure 42: Other Product Growth
目次

OVERVIEW:

The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. The New Demand for Clinical Testing
  • 2.2. Defining the Opportunity
    • 2.2.1. Revenue Market Size
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Overview of a Dynamic Market

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Segmentation-Different Approaches
    • 3.2.1. Traditional Market Segmentation
    • 3.2.2. Laboratory Focus and Segmentation
  • 3.3. Structure of Clinical Testing Industry
    • 3.3.1. The Hospital Lab-Share of the Pie
    • 3.3.2. Key Role for Economies of Scale
    • 3.3.3. Physician Office Lab's are Still Here
    • 3.3.4. Physician's and POCT-Reviving Patient Service in China
  • 3.4. National and Regional Diversity

4. Trends Driving a Changing Market

  • 4.1. Growth Is Pushed from Many Sides
    • 4.1.1. Demographic Impacts on Consumption
    • 4.1.2. COVID Related Impacts
    • 4.1.3. Point of Care Testing Makes a Difference
    • 4.1.4. Alternative Medicine Effect
    • 4.1.5. Esoterics
    • 4.1.6. A New Laboratory Discipline
  • 4.2. Factors at Work to Shrink the Market
    • 4.2.1. Where are Costs Going?
    • 4.2.2. Population Effects
    • 4.2.3. Management Practices
    • 4.2.4. Wellness
    • 4.2.5. Cannabilization
    • 4.2.6. Point of Care
  • 4.3. Automation and Laboratory Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point Of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Clinical Laboratory Services Recent Developments

  • 5.1. Recent Developments-Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. Atalan Sees Potential in Hospital Outreach Business
  • 5.3. Challenge Bringing Routine Testing to Point of Care
  • 5.4. Natera Cites Test Volume Growth, Rosy Reimbursement
  • 5.5. Patients Becoming Stakeholders in Infectious Disease Testing
  • 5.6. MedGenome Acquires Prognosis Laboratories
  • 5.7. Brooks Automation acquires Aim Lab
  • 5.8. Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO
  • 5.9. Mayo Clinic Laboratories and Helix to provide Biopharma Services
  • 5.10. CompuGroup Medical acquires Medicus Laboratory Information Systems
  • 5.11. Quest Diagnostics acquires Summa Health outreach lab
  • 5.12. Q2 Solutions Launches Self-Collection Safety Lab Panel
  • 5.13. Bionano Genomics Announces Launch of Bionano Laboratories
  • 5.14. Labcorp to Spin Off Clinical Development Business
  • 5.15. Value-Based Care Growing More Profitable for Labs
  • 5.16. Lucid Diagnostics Reports Revenue Growth
  • 5.17. NGS Cancer Testing Decision Appeases Industry
  • 5.18. Clinical Labs Make Strong Showing in 2021
  • 5.19. Seegene to Enter Syndromic MDx Space
  • 5.20. EKF Diagnostics Acquires Advanced Diagnostic Laboratory
  • 5.21. Molecular Health, EDGC Ink Liquid Biopsy Partnership
  • 5.22. ProPhase Labs Acquires Nebula Genomics for $14.6M
  • 5.23. Karius Cell-Free DNA Method to Detect Infection Validated
  • 5.24. EDGC Enters Liquid Biopsy Space With Cf DNA
  • 5.25. TruDiagnostic Receives CLIA Certification for Kentucky Laboratory
  • 5.26. Enzo Biochem Q2 Revenues Up 62 Percent
  • 5.27. Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
  • 5.28. FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
  • 5.29. Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
  • 5.30. Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing
  • 5.31. Cooperative Aims to Expand Clinical, Commercial NGS Access

6. Profiles of Key Companies

  • 6.1. Acibadem Labmed Laboratory
  • 6.2. ACM Medical Laboratory
  • 6.3. Adicon Clinical Laboratories
  • 6.4. American Bio-Clinical Laboratories, Int'l
  • 6.5. ARUP Laboratories
  • 6.6. Ascend Clinical
  • 6.7. Assurance Scientific Laboratories
  • 6.8. Bio-Reference Laboratories
  • 6.9. Bioscientia Institut für Medizinische Diagnostik GmbH
  • 6.10. BP Healthcare Group
  • 6.11. Clinical Reference Laboratory
  • 6.12. Clongen Laboratories
  • 6.13. CompuNet Clinical Laboratories
  • 6.14. Diagnósticos da América
  • 6.15. DIAN Diagnostics Co., Ltd.
  • 6.16. Enzo Biochem
  • 6.17. Eone Laboratories
  • 6.18. Eurofins Scientific
  • 6.19. Exagen Diagnostics
  • 6.20. Genzyme Corporation
  • 6.21. Gribbles Pathology
  • 6.22. Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • 6.23. Integrated Regional Laboratories
  • 6.24. KDL Group
  • 6.25. Laboratory Corporation of America
  • 6.26. Lifelabs
  • 6.27. Mayo Clinic Laboratories
  • 6.28. Mid America Clinical Laboratories
  • 6.29. MNG Labs
  • 6.30. Myriad Genetics/Myriad RBM
  • 6.31. NeoGenomics
  • 6.32. OncoDNA
  • 6.33. Pathology, Inc.
  • 6.34. ProPhase Labs
  • 6.35. Psychemedics Corporation
  • 6.36. Quest Diagnostics
  • 6.37. RDL Reference Laboratory
  • 6.38. Sonic Healthcare
  • 6.39. Sophia Genetics
  • 6.40. Spectra Laboratories
  • 6.41. Synlab
  • 6.42. Sysmex Inostics
  • 6.43. Unilabs
  • 6.44. Werfen

7. The Global Market for Clinical Laboratory Testing

  • 7.1. Global Market Overview by Country
    • 7.1.1. Table-Global Market by Country
    • 7.1.2. Chart - Global Market by Country
  • 7.2. Global Market by Assay Type - Overview
    • 7.2.1. Table-Global Market by Assay Type
    • 7.2.2. Chart-Global Market by Assay Type-Base/Final Year Comparison
    • 7.2.3. Chart-Global Market by Assay Type-Base Year
    • 7.2.4. Chart-Global Market by Assay Type-End Year
    • 7.2.5. Chart-Global Market by Assay Type-Share by Year
    • 7.2.6. Chart-Global Market by Assay Type-Segments Growth
  • 7.3. Global Market by Place - Overview
    • 7.3.1. Table-Global Market by Place
    • 7.3.2. Chart-Global Market by Place-Base/Final Year Comparison
    • 7.3.3. Chart-Global Market by Place-Base Year
    • 7.3.4. Chart-Global Market by Place-End Year
    • 7.3.5. Chart-Global Market by Place-Share by Year
    • 7.3.6. Chart-Global Market by Place-Segments Growth
  • 7.4. Global Market by Product - Overview
    • 7.4.1. Table-Global Market by Product
    • 7.4.2. Chart-Global Market by Product-Base/Final Year Comparison
    • 7.4.3. Chart-Global Market by Product-Base Year
    • 7.4.4. Chart-Global Market by Product-End Year
    • 7.4.5. Chart-Global Market by Product-Share by Year
    • 7.4.6. Chart-Global Market by Product-Segments Growth

8. Global Clinical Laboratory Diagnostic Markets-By Assay Type

  • 8.1. Chemistry
    • 8.1.1. Table Chemistry-by Country
    • 8.1.2. Chart - Chemistry Growth
  • 8.2. Microbiology
    • 8.2.1. Table Microbiology-by Country
    • 8.2.2. Chart - Microbiology Growth
  • 8.3. Hematology
    • 8.3.1. Table Hematology-by Country
    • 8.3.2. Chart - Hematology Growth
  • 8.4. Anatomic Pathology
    • 8.4.1. Table Anatomic Pathology-by Country
    • 8.4.2. Chart - Anatomic Pathology Growth
  • 8.5. Molecular Diagnostics
    • 8.5.1. Table Molecular Diagnostics-by Country
    • 8.5.2. Chart - Molecular Diagnostics Growth
  • 8.6. Esoteric
    • 8.6.1. Table Esoteric-by Country
    • 8.6.2. Chart - Esoteric Growth

9. Global Clinical Laboratory Diagnostic Markets-By Place

  • 9.1. In Patient Hospital
    • 9.1.1. Table In Patient Hospital-by Country
    • 9.1.2. Chart - In Patient Hospital Growth
  • 9.2. Out Patient Hospital
    • 9.2.1. Table Out Patient Hospital-by Country
    • 9.2.2. Chart - Out Patient Hospital Growth
  • 9.3. Independent Laboratory
    • 9.3.1. Table Independent Laboratory-by Country
    • 9.3.2. Chart - Independent Laboratory Growth
  • 9.4. Physicians Office Laboratory
    • 9.4.1. Table Physicians Office Laboratory-by Country
    • 9.4.2. Chart - Physicians Office Laboratory Growth
  • 9.5. Other Laboratory
    • 9.5.1. Table Other Laboratory-by Country
    • 9.5.2. Chart - Other Laboratory Growth

10. Global Clinical Laboratory Diagnostic Markets-By Product

  • 10.1. Instruments
    • 10.1.1. Table Instruments-by Country
    • 10.1.2. Chart - Instruments Growth
  • 10.2. Reagents
    • 10.2.1. Table Reagents-by Country
    • 10.2.2. Chart - Reagents Growth
  • 10.3. Labour
    • 10.3.1. Table Labour-by Country
    • 10.3.2. Chart - Labour Growth
  • 10.4. Overhead
    • 10.4.1. Table Overhead-by Country
    • 10.4.2. Chart - Overhead Growth
  • 10.5. Other Product
    • 10.5.1. Table Other Product-by Country
    • 10.5.2. Chart - Other Product Growth

11. The Future of the Clinical Laboratory

12. Appendices

  • 12.1. United States Medicare System: Clinical Laboratory Fees Schedule
  • 12.2. The Most Used IVD Assays
  • 12.3. The Highest Grossing Assays